FDA
approval
· 2015-09-17
FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' lamivudine and zidovudine as an original application, a generic fixed-dose combination for HIV-1 infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)